Cross Country Healthcare Stock EBITDA
| XXY Stock | EUR 10.10 0.10 0.98% |
Cross Country Healthcare fundamentals help investors to digest information that contributes to Cross Country's financial success or failures. It also enables traders to predict the movement of Cross Stock. The fundamental analysis module provides a way to measure Cross Country's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cross Country stock.
Cross |
Cross Country Healthcare Company EBITDA Analysis
Cross Country's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Cross Country EBITDA | 283.29 M |
Most of Cross Country's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cross Country Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Cross Country Healthcare reported earnings before interest,tax, depreciation and amortization of 283.29 M. This is 51.37% lower than that of the Industrials sector and 67.26% higher than that of the Staffing & Outsourcing Services industry. The ebitda for all Germany stocks is 92.73% higher than that of the company.
Cross EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cross Country's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cross Country could also be used in its relative valuation, which is a method of valuing Cross Country by comparing valuation metrics of similar companies.Cross Country is currently under evaluation in ebitda category among its peers.
Cross Fundamentals
| Return On Equity | 0.5 | |||
| Return On Asset | 0.21 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 1.18 B | |||
| Shares Outstanding | 36.82 M | |||
| Shares Owned By Insiders | 5.37 % | |||
| Shares Owned By Institutions | 99.85 % | |||
| Price To Earning | 6.82 X | |||
| Price To Book | 2.66 X | |||
| Price To Sales | 0.35 X | |||
| Revenue | 2.81 B | |||
| Gross Profit | 627.69 M | |||
| EBITDA | 283.29 M | |||
| Net Income | 188.46 M | |||
| Cash And Equivalents | 24.83 M | |||
| Cash Per Share | 0.67 X | |||
| Total Debt | 148.74 M | |||
| Debt To Equity | 59.00 % | |||
| Current Ratio | 1.99 X | |||
| Book Value Per Share | 12.60 X | |||
| Cash Flow From Operations | 134.05 M | |||
| Earnings Per Share | 5.67 X | |||
| Price To Earnings To Growth | 0.96 X | |||
| Target Price | 20.71 | |||
| Number Of Employees | 2.7 K | |||
| Beta | 1.05 | |||
| Market Capitalization | 925.43 M | |||
| Total Asset | 947.84 M | |||
| Z Score | 5.6 | |||
| Net Asset | 947.84 M |
About Cross Country Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cross Country Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cross Country using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cross Country Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Cross Stock
When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.